These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

166 related articles for article (PubMed ID: 10723489)

  • 21. [The hydro-MRT of chronic inflammatory bowel diseases].
    Hansmann HJ; Kosa R; Düx M; Brado M; Goeser T; Roeren T; Stremmel W; Kauffmann GW
    Rofo; 1997 Aug; 167(2):132-8. PubMed ID: 9333353
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Role of spectral presaturation attenuated inversion-recovery fat-suppressed T2-weighted MR imaging in active inflammatory bowel disease.
    Udayasankar UK; Martin D; Lauenstein T; Rutherford R; Galloway J; Tudorascu D; Sitaraman SV
    J Magn Reson Imaging; 2008 Nov; 28(5):1133-40. PubMed ID: 18972354
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Assessment of Crohn's disease activity in the small bowel with MR-enteroclysis: clinico-radiological correlations.
    Malagò R; Manfredi R; Benini L; D'Alpaos G; Mucelli RP
    Abdom Imaging; 2008; 33(6):669-75. PubMed ID: 18228087
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Dynamic contrast-enhanced MRI in patients with luminal Crohn's disease.
    Ziech ML; Lavini C; Caan MW; Nio CY; Stokkers PC; Bipat S; Ponsioen CY; Nederveen AJ; Stoker J
    Eur J Radiol; 2012 Nov; 81(11):3019-27. PubMed ID: 22749801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Magnetic resonance enteroclysis in the diagnosis of small-intestinal Crohn's disease: diagnostic accuracy and inter- and intra-observer agreement.
    Negaard A; Sandvik L; Mulahasanovic A; Berstad AE; Klöw NE
    Acta Radiol; 2006 Dec; 47(10):1008-16. PubMed ID: 17135001
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Magnetic resonance for assessment of disease activity and severity in ileocolonic Crohn's disease.
    Rimola J; Rodriguez S; García-Bosch O; Ordás I; Ayala E; Aceituno M; Pellisé M; Ayuso C; Ricart E; Donoso L; Panés J
    Gut; 2009 Aug; 58(8):1113-20. PubMed ID: 19136510
    [TBL] [Abstract][Full Text] [Related]  

  • 27. MRI of the small bowel with oral contrast or nasojejunal intubation in Crohn's disease: randomized comparison of patient acceptance.
    Negaard A; Sandvik L; Berstad AE; Paulsen V; Lygren I; Borthne A; Klow NE
    Scand J Gastroenterol; 2008 Jan; 43(1):44-51. PubMed ID: 18158695
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Magnetic resonance imaging of the small bowel in Crohn's disease.
    Frøkjaer JB; Larsen E; Steffensen E; Nielsen AH; Drewes AM
    Scand J Gastroenterol; 2005 Jul; 40(7):832-42. PubMed ID: 16109660
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Feasibility of evaluating Crohn's disease activity at 3.0 Tesla.
    van Gemert-Horsthuis K; Florie J; Hommes DW; Lavini C; Reitsma JB; van Deventer SJ; Stoker J
    J Magn Reson Imaging; 2006 Aug; 24(2):340-8. PubMed ID: 16786589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Magnetic Resonance enteroclysis imaging in Crohn's disease.
    Broglia L; Gigante P; Papi C; Ferrari R; Gili L; Capurso L; Castrucci M
    Radiol Med; 2003; 106(1-2):28-35. PubMed ID: 12951548
    [TBL] [Abstract][Full Text] [Related]  

  • 31. MRI evaluation of inflammatory activity in Crohn's disease.
    Sempere GA; Martinez Sanjuan V; Medina Chulia E; Benages A; Tome Toyosato A; Canelles P; Bulto A; Quiles F; Puchades I; Cuquerella J; Celma J; Orti E
    AJR Am J Roentgenol; 2005 Jun; 184(6):1829-35. PubMed ID: 15908538
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Urinary excretion of N-methylhistamine as a marker of disease activity in inflammatory bowel disease.
    Winterkamp S; Weidenhiller M; Otte P; Stolper J; Schwab D; Hahn EG; Raithel M
    Am J Gastroenterol; 2002 Dec; 97(12):3071-7. PubMed ID: 12492192
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Imaging for Crohn disease: use of 3-T MRI in a paediatric setting.
    Dagia C; Ditchfield M; Kean M; Catto-Smith T
    J Med Imaging Radiat Oncol; 2008 Oct; 52(5):480-8. PubMed ID: 19032394
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [The usefulness of reactive protein C in managing patients with ulcerative colitis and Crohn's disease].
    López Morante AJ; Sáez-Royuela F; Yuguero del Moral L; Martín Lorente JL; Ojeda Giménez C
    Rev Esp Enferm Dig; 1993 Jan; 83(1):5-9. PubMed ID: 8452705
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Crohn's disease lymphadenopathy: MR imaging findings.
    Gourtsoyianni S; Papanikolaou N; Amanakis E; Bourikas L; Roussomoustakaki M; Grammatikakis J; Gourtsoyiannis N
    Eur J Radiol; 2009 Mar; 69(3):425-8. PubMed ID: 19101103
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Mapping of T1-values and Gadolinium-concentrations in MRI as indicator of disease activity in luminal Crohn's disease: a feasibility study.
    Horsthuis K; Nederveen AJ; de Feiter MW; Lavini C; Stokkers PC; Stoker J
    J Magn Reson Imaging; 2009 Feb; 29(2):488-93. PubMed ID: 19161209
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Retrospective comparison of magnetic resonance imaging features and histopathology in Crohn's disease patients.
    Ziech ML; Bipat S; Roelofs JJ; Nio CY; Mearadji B; van Doorn S; Spijkerboer AM; Stoker J
    Eur J Radiol; 2011 Dec; 80(3):e299-305. PubMed ID: 21295932
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Dynamic MRI of the small bowel: usefulness of quantitative contrast-enhancement parameters and time-signal intensity curves for differentiating between active and inactive Crohn's disease.
    Giusti S; Faggioni L; Neri E; Fruzzetti E; Nardini L; Marchi S; Bartolozzi C
    Abdom Imaging; 2010 Dec; 35(6):646-53. PubMed ID: 20509025
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Fecal calprotectin correlates more closely with the Simple Endoscopic Score for Crohn's disease (SES-CD) than CRP, blood leukocytes, and the CDAI.
    Schoepfer AM; Beglinger C; Straumann A; Trummler M; Vavricka SR; Bruegger LE; Seibold F
    Am J Gastroenterol; 2010 Jan; 105(1):162-9. PubMed ID: 19755969
    [TBL] [Abstract][Full Text] [Related]  

  • 40. C-reactive protein: a predictive factor and marker of inflammation in inflammatory bowel disease. Results from a prospective population-based study.
    Henriksen M; Jahnsen J; Lygren I; Stray N; Sauar J; Vatn MH; Moum B;
    Gut; 2008 Nov; 57(11):1518-23. PubMed ID: 18566104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.